Biosearch Licenses IP to DuPont for Food Dx Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DuPont Qualicon will have access to Biosearch Technologies' BHQ, CAL Fluor, and Quasar patents under a licensing agreement announced today.

As part of the deal, Biosearch will also manufacture Scorpions primer oligonucleotides for use in food diagnostics by DuPont. This past summer, Biosearch signed an agreement with Qiagen, expanding its rights to the Scorpions primer technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.